Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1998 Nov;125(5):1005–1012. doi: 10.1038/sj.bjp.0702162

The action of calcium channel blockers on recombinant L-type calcium channel α1-subunits

Nicole Morel 1,*, Vitali Buryi 1, Olivier Feron 1,2, Jean-Pierre Gomez 1,3, Marie-Odile Christen 1,4, Théophile Godfraind 1
PMCID: PMC1565671  PMID: 9846638

Abstract

  1. CHO cells expressing the α1C-a subunit (cardiac isoform) and the α1C-b subunit (vascular isoform) of the voltage-dependent L-type Ca2+ channel were used to investigate whether tissue selectivity of Ca2+ channel blockers could be related to different affinities for α1C isoforms.

  2. Inward current evoked by the transfected α1 subunit was recorded by the patch-clamp technique in the whole-cell configuration.

  3. Neutral dihydropyridines (nifedipine, nisoldipine, (+)-PN200-110) were more potent inhibitors of α1C-b-subunit than of α1C-a-subunit. This difference was more marked at a holding potential of −100 mV than at −50 mV. SDZ 207-180 (an ionized dihydropyridine) exhibited the same potency on the two isoforms.

  4. Pinaverium (ionized non-dihydropyridine derivative) was 2 and 4 fold more potent on α1C-a than on α1C-b subunit at Vh of −100 mV and −50 mV, respectively. Effects of verapamil were identical on the two isoforms at both voltages.

  5. [3H]-(+)-PN 200-110 binding experiments showed that neutral dihydropyridines had a higher affinity for the α1C-b than for the α1C-a subunit. SDZ 207-180 had the same affinity for the two isoforms and pinaverium had a higher affinity for the α1C-a subunit than for the α1C-b subunit.

  6. These results indicate marked differences among Ca2+ channel blockers in their selectivity for the α1C-a and α1C-b subunits of the Ca2+ channel.

Keywords: L-type Ca2+ channels, α1-subunit, Ca2+ channel blocker, tissue selectivity, dihydropyridine, verapamil, patch-clamp

Full Text

The Full Text of this article is available as a PDF (361.5 KB).


Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES